PRA Health Sciences (PRAH) Tops Q3 EPS by 6c, Offers FY Guidance
Get Alerts PRAH Hot Sheet
Join SI Premium – FREE
PRA Health Sciences (NASDAQ: PRAH) reported Q3 EPS of $1.13, $0.06 better than the analyst estimate of $1.07. Revenue for the quarter came in at $717.6 million versus the consensus estimate of $726.88 million.
GUIDANCE:
PRA Health Sciences sees FY2018 EPS of $4.22-$4.27, versus the consensus of $4.19. PRA Health Sciences sees FY2018 revenue of $2.87-2.92 billion, versus the consensus of $2.91 billion.
For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- China Automotive Systems (CAAS) Tops Q4 EPS by 24c ; Offers Guidance
- VNET Group (VNET) Tops Q4 EPS by 18c, provides guidance
- MillerKnoll, Inc. (MLKN) Tops Q3 EPS by 1c; offers Q4 guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!